The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Metals Regulatory News (FME)

Share Price Information for Future Metals (FME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.45
Bid: 1.40
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.10 (7.143%)
Open: 1.45
High: 1.45
Low: 1.45
Prev. Close: 1.45
FME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Director Performance Rights

22 Nov 2023 07:00

RNS Number : 1793U
Future Metals NL
22 November 2023
 

22 November 2023

Future Metals NL

 

Grant of Director Performance Rights

 

 

Further to the approval of Resolution 7 at its recent Annual General Meeting ("AGM"), Future Metals NL ("Future Metals" or the "Company", ASX | AIM: FME) announces that on 21 November 2023 it issued 20,000,000 Performance Rights to Mr Patrick Walta, Executive Chair of the Company, on the terms and conditions set out in the Explanatory Statement accompanying the Notice of AGM.

 

Under the Company's Performance Rights Plan, the 20,000,000 Performance Rights are exercisable for nil consideration up to and including 21 November 2026 and are subject to the vesting criteria outlined in the table below:

 

Performance Criteria

No. of Performance Rights

Volume weighted average share price over 5-days ("5-day VWAP") of Future Metals' shares trading on the ASX exceeds 10 cents

 

5,000,000

5-day VWAP of Future Metals' shares trading on the ASX exceeds 20 cents

 

5,000,000

12 months of continuous employment from the date of 20 November 2023

2,500,000

24 months of continuous employment from the date of 20 November 2023

 

2,500,000

Obtaining >20% institutional ownership of Future Metals shares; or a strategic partner for Panton (at asset or Company level); or a >10% individual cornerstone shareholder in the Company

 

2,500,000

Completion of a Scoping Study that supports a Board decision to proceed with a pre-feasibility study or definitive feasibility study

 

2,500,000

Total

20,000,000

 

 

Further details are provided in the below PDMR Notification Form, announced in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

This announcement has been approved for release by the Board of Future Metals NL.

 

 

Further Information

For further information please refer to the ASX platform under ASX code FME or visit the Company's website at www.future-metals.com.au.

 

Future Metals NL

+61 8 9480 0414

Jardee Kininmonth

info@future-metals.com.au

Strand Hanson Limited (Nominated Adviser)

+44 (0) 207 409 3494

James Harris/James Bellman

Panmure Gordon (UK) Limited (UK Broker)

John Prior/Hugh Rich/Rauf Munir

+44 (0)207 886 2500

FlowComms (UK IR/PR)

+44 (0) 789 167 7441

Sasha Sethi

 

 

PDMR Notification Form:

 

The notification below is made in accordance with the requirements of MAR.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Patrick Walta

2.

Reason for the Notification

a)

Position/status

Executive Chair

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Future Metals NL

b)

LEI

213800WZ1MNQPOAKNU50

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Performance Rights over ordinary shares of no par value in the capital of the Company

Identification code

AU0000157745

b)

Nature of the Transaction

Grant of Performance Rights over ordinary shares of no par value in the capital of the Company

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

20,000,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

21 November 2023

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBQQBDDODB
Date   Source Headline
3rd May 202410:15 amRNSProposed Options Entitlement Offer
29th Apr 20249:18 amRNSQuarterly Activities Report
27th Mar 20247:00 amRNSBoard and Management Changes
22nd Mar 20246:05 pmRNSReplacement: Non-Executive Board Changes
22nd Mar 202411:30 amRNSNon-Executive Board Changes
15th Mar 20249:30 amRNSResults for the Half-Year Ended 31 December 2023
1st Mar 20242:00 pmRNSIssue of Equity
23rd Feb 202410:00 amRNSRecording of the 2024 RIU Explorers Conference
15th Feb 20247:00 amRNSInvestor Presentation
8th Feb 20247:00 amRNSResult of Entitlement Issue & Directors' Dealings
31st Jan 20247:00 amRNSQuarterly Activities Report
17th Jan 20248:42 amRNSCompany Update
15th Jan 20248:01 amRNSExtension of Closing Date
11th Jan 20249:18 amRNSReplacement: Entitlement Issue Update
11th Jan 20247:00 amRNSEntitlement Issue Update
9th Jan 20247:00 amRNSRestricted Securities to be Released from Escrow
29th Dec 20237:00 amRNSEntitlement Issue Details for DI Holders
15th Dec 20237:00 amRNSUnderwritten Entitlement Issue to Raise A$3.3m
13th Dec 20237:00 amRNSASX Trading Halt
7th Dec 20237:01 amRNSInvestor Webinar
7th Dec 20237:00 amRNSPanton Scoping Study
23rd Nov 20238:15 amRNSPerformance Rights Conversion
22nd Nov 20237:00 amRNSGrant of Director Performance Rights
20th Nov 20237:00 amRNSResult of AGM and Board Changes
17th Nov 20238:35 amRNSAcquisition of Osprey
15th Nov 20237:00 amRNSBoard Changes and AGM Resolutions Updates
6th Nov 20237:00 amRNSVariation to Option Agreement
31st Oct 20232:45 pmRNSInvestor Webinar
31st Oct 20237:00 amRNSQuarterly Activities Report
26th Oct 20237:02 amRNSPanton Resource Upgrade
19th Oct 20237:00 amRNSNotice of AGM
9th Oct 20234:10 pmRNSAppointment of Executive Chair and Board Changes
5th Oct 20237:00 amRNSFME Doubles Strategic Exploration Position
29th Sep 20237:00 amRNSAnnual Financial Report
18th Sep 20237:00 amRNSChange of Australian Share Registry Address
27th Jul 20237:00 amRNSQuarterly Activities Report to 30 June 2023
11th Jul 20237:15 amRNSStep Change in PGM Recovery - Improved to 86%
10th Jul 20237:30 amRNSPerformance Rights Conversion and TVR
27th Jun 20237:30 amRNSExpiry of Options
8th Jun 20237:00 amRNSInvestor Webinar
7th Jun 20238:00 amRNSRestricted Securities to be Released from Escrow
24th May 20237:00 amRNSRC Drilling Commences at Panton Ni-Cu-PGM Targets
4th May 20237:00 amRNSDrilling to Commence at Nickel Sulphide Targets
28th Apr 20237:00 amRNSQuarterly Activities Report to 31 March 2023
21st Mar 20237:00 amRNSHigh Grade Mineralisation Intersected
15th Mar 202310:16 amRNSResults for the Half-Year Ended 31 December 2022
13th Feb 20238:31 amRNSMining and Processing Breakthrough at Panton
2nd Feb 20238:55 amRNSLarge Ni-Cu-(PGE) Sulphide Zone Identified
20th Jan 20237:00 amRNSAdmission of Consideration Shares
19th Jan 20237:00 amRNSQuarterly Activities Report to 31 December 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.